ICTS Complutense Bioimaging

Research Assistance Centres

1st Call 2024 for Competitive Open Access (COA)


The 1st Call for the year 2024 for Competitive Open Access (COA) to the Singular Infrastructures of the ICTS ReDIB, of which BioImagen Complutense (BioImaC) is a member, is open since April 1st.


In this call BioImaC offers once again very advantageous conditions of access to its unique equipment:

  • 120 hours of acquisitions in the MRI ICON 1T at zero cost (consumables such as anaesthetics, contrast agents, oxygen, etc. are not included, which will be invoiced at the unit prices indicated on the BioImaC website).
  • Supply of 18F and 18FNa in accordance with the collaboration agreement signed between UCM and Curium Pharma Spain S.A.

The deadlines established for this 1st Call AAC 2024 are:

  • Submission of applications: online at the ReDIB website, from 1 to 30 April.
  • Evaluation of applications by the ReDIB Access Committee: from 1 to 31 May.
  • Performance of awarded accesses: from 1 June to 30 September.

The access protocol and the application evaluation procedure are published on the ReDIB ICTS website.

More information at BioImaC.